1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Mark Gladwin: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multi-Center Study of Riociguat in Patients With Sickle Cell Diseases Riociguat, Placebo - Sickle Cell Disease | Phase 2 | Completed | Mark Gladwin | 130 | 2017-04-11 | 2023-07-19 |
riociguat (1)
United States (1)